These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30725008)

  • 1. Yellow fever vaccination for Chilean tourists visiting Brazil. Practical considerations.
    Weitzel T; Perret C; Valdivieso F; Abarca K; Vial P
    Rev Chilena Infectol; 2018; 35(5):587-590. PubMed ID: 30725008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortage of yellow fever vaccination: A travel medicine emergency for Chilean travellers.
    Weitzel T; Vial P; Perret C; Aguilera X
    Travel Med Infect Dis; 2019; 28():1-2. PubMed ID: 30708130
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for travellers during the yellow fever outbreaks in Brazil-2018.
    Fujita DM; da Silva Nali LH; Salvador FS; de Andrade Júnior HF
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635644
    [No Abstract]   [Full Text] [Related]  

  • 4. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 6. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group].
    Martinho C; Lopes D; Bastos L; Esteves H
    Acta Med Port; 2018 Dec; 31(12):724-729. PubMed ID: 30684369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccination and neurological complications.
    Bayão TS; Cupertino MDC; Gomes AP; Siqueira-Batista R
    Rev Soc Bras Med Trop; 2018; 51(5):723-724. PubMed ID: 30304289
    [No Abstract]   [Full Text] [Related]  

  • 9. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018.
    Gossner CM; Haussig JM; de Bellegarde de Saint Lary C; Kaasik Aaslav K; Schlagenhauf P; Sudre B
    Euro Surveill; 2018 Mar; 23(11):. PubMed ID: 29560853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional dosing of yellow fever vaccine during shortages: perspective from Canada.
    Teitelbaum P; Bui YG; Libman M; McCarthy A
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346564
    [No Abstract]   [Full Text] [Related]  

  • 12. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Yellow fever in Brazil: the importance of vaccination].
    Vermeij A; Slobbe L; GeurtsvanKessel CH; van Nood E; Reusken CBEM; van Genderen PJJ
    Ned Tijdschr Geneeskd; 2018 Sep; 162():. PubMed ID: 30358370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical aspects of yellow fever control in Brazil.
    Tauil PL
    Rev Saude Publica; 2010 Jun; 44(3):555-8. PubMed ID: 20499010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever vaccine as a vehicle to better travel medicine.
    Spira A
    J Travel Med; 2005; 12(6):303-5. PubMed ID: 16343380
    [No Abstract]   [Full Text] [Related]  

  • 17. Late vaccination against yellow fever of travelers visiting endemic countries.
    Krief I; Goldblatt JG; Paz A; Potasman I
    Travel Med Infect Dis; 2006 Mar; 4(2):94-8. PubMed ID: 16887731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?
    Wyplosz B; Leroy JP; Derradji O; Consigny PH
    J Travel Med; 2015; 22(2):140-1. PubMed ID: 25384441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zika virus infection, associated microcephaly, and low yellow fever vaccination coverage in Brazil: is there any causal link?
    De Góes Cavalcanti LP; Tauil PL; Alencar CH; Oliveira W; Teixeira MM; Heukelbach J
    J Infect Dev Ctries; 2016 Jun; 10(6):563-6. PubMed ID: 27367003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.